National Hospital Organization Nagoya Medical Center ( Site 6903)

Nagoya, Aichi-ken 460-0001

0 studies enrolling now · 1 studies all time

What they study most

HIV-1 Infection

Studies at this site

• Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020) — Completed